P/E ratio for Teladoc Health (TDOC)
P/E ratio as of April 2025 (TTM): -0.3147
According to Teladoc Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.31468. At the end of 2022 the company had a P/E ratio of -0.2791.
P/E ratio history for Teladoc Health from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.2791 | -99.16% |
| 2021 | -33.1 | -29.71% |
| 2020 | -47.2 | -22.26% |
| 2019 | -60.7 | 81.13% |
| 2018 | -33.5 | 81.64% |
| 2017 | -18.4 | 92.21% |
| 2016 | -9.59 | -14.99% |
| 2015 | -11.3 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 1.42 | -549.76% | 🇺🇸 USA |
 | -12.2 | 3,783.31% | 🇺🇸 USA |
 | 19.5 | -6,304.05% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.